Pharma-Bio Serv, Inc. (PBSV)
USD 0.38
(-21.86%)
USD 0.38
(-21.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.31 Million USD | 6.99% |
| 2022 | 1.22 Million USD | 132.43% |
| 2021 | -3.78 Million USD | -263.55% |
| 2020 | 2.31 Million USD | 28.74% |
| 2019 | 1.79 Million USD | 54.43% |
| 2018 | 1.16 Million USD | 216.84% |
| 2017 | -710.02 Thousand USD | -399.07% |
| 2016 | 220.79 Thousand USD | -84.58% |
| 2015 | 2.15 Million USD | -33.54% |
| 2014 | 3.24 Million USD | -49.48% |
| 2013 | 6.41 Million USD | 5.94% |
| 2012 | 6.08 Million USD | 59.96% |
| 2011 | 3.79 Million USD | 300.66% |
| 2010 | 948.5 Thousand USD | -24.26% |
| 2009 | 1.25 Million USD | -56.62% |
| 2008 | 2.96 Million USD | -25.78% |
| 2007 | 3.85 Million USD | -4.93% |
| 2006 | 4.08 Million USD | 20514.44% |
| 2005 | -20 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -268.7 Thousand USD | 28.57% |
| 2024 Q3 | -337.38 Thousand USD | -9.59% |
| 2024 Q1 | -392.72 Thousand USD | -523.14% |
| 2023 Q1 | 344.75 Thousand USD | 89.68% |
| 2023 Q4 | 101.86 Thousand USD | -78.41% |
| 2023 Q3 | 471.86 Thousand USD | 19.99% |
| 2023 FY | - USD | 6.99% |
| 2023 Q2 | 393.24 Thousand USD | 14.06% |
| 2022 FY | - USD | 132.43% |
| 2022 Q3 | 382.46 Thousand USD | 30.64% |
| 2022 Q2 | 292.77 Thousand USD | -20.67% |
| 2022 Q1 | 369.05 Thousand USD | 107.71% |
| 2022 Q4 | 181.76 Thousand USD | -52.48% |
| 2021 Q2 | 283.61 Thousand USD | -16.72% |
| 2021 FY | - USD | -263.55% |
| 2021 Q1 | 340.54 Thousand USD | 97.78% |
| 2021 Q3 | 378.67 Thousand USD | 33.52% |
| 2021 Q4 | -4.78 Million USD | -1363.3% |
| 2020 Q4 | 172.18 Thousand USD | -79.5% |
| 2020 Q1 | 557.79 Thousand USD | 23.45% |
| 2020 FY | - USD | 28.74% |
| 2020 Q2 | 741.96 Thousand USD | 33.02% |
| 2020 Q3 | 839.89 Thousand USD | 13.2% |
| 2019 FY | - USD | 54.43% |
| 2019 Q4 | 451.85 Thousand USD | 17.12% |
| 2019 Q1 | 459.33 Thousand USD | -45.96% |
| 2019 Q2 | 498.77 Thousand USD | 8.58% |
| 2019 Q3 | 385.81 Thousand USD | -22.65% |
| 2018 Q4 | 850.01 Thousand USD | 62.85% |
| 2018 Q3 | 521.97 Thousand USD | 13976.89% |
| 2018 Q2 | 3708.00 USD | -97.55% |
| 2018 Q1 | 151.06 Thousand USD | 142.84% |
| 2018 FY | - USD | 216.84% |
| 2017 Q4 | -352.61 Thousand USD | -154.33% |
| 2017 Q3 | -138.64 Thousand USD | 38.61% |
| 2017 Q2 | -225.83 Thousand USD | 18.81% |
| 2017 Q1 | -278.14 Thousand USD | 9.07% |
| 2017 FY | - USD | -399.07% |
| 2016 Q3 | -46.07 Thousand USD | -120.59% |
| 2016 Q4 | -305.88 Thousand USD | -563.86% |
| 2016 Q1 | 461 Thousand USD | -30.77% |
| 2016 Q2 | 223.73 Thousand USD | -51.47% |
| 2016 FY | - USD | -84.58% |
| 2015 Q1 | 421.06 Thousand USD | -58.66% |
| 2015 FY | - USD | -33.54% |
| 2015 Q4 | 665.93 Thousand USD | 13.72% |
| 2015 Q3 | 585.61 Thousand USD | 20.74% |
| 2015 Q2 | 485 Thousand USD | 15.19% |
| 2014 Q3 | 792.95 Thousand USD | 53.68% |
| 2014 Q4 | 1.01 Million USD | 28.45% |
| 2014 Q1 | 919.27 Thousand USD | -42.46% |
| 2014 FY | - USD | -49.48% |
| 2014 Q2 | 515.96 Thousand USD | -43.87% |
| 2013 Q4 | 1.59 Million USD | -1.49% |
| 2013 FY | - USD | 5.94% |
| 2013 Q3 | 1.62 Million USD | -11.54% |
| 2013 Q2 | 1.83 Million USD | 33.46% |
| 2013 Q1 | 1.37 Million USD | -6.28% |
| 2012 FY | - USD | 59.96% |
| 2012 Q4 | 1.46 Million USD | -11.45% |
| 2012 Q3 | 1.65 Million USD | 10.1% |
| 2012 Q2 | 1.5 Million USD | 4.26% |
| 2012 Q1 | 1.44 Million USD | 27.67% |
| 2011 Q3 | 1.25 Million USD | 53.43% |
| 2011 Q4 | 1.12 Million USD | -9.7% |
| 2011 FY | - USD | 300.66% |
| 2011 Q1 | 597 Thousand USD | 65.86% |
| 2011 Q2 | 815.23 Thousand USD | 36.55% |
| 2010 FY | - USD | -24.26% |
| 2010 Q2 | 163.61 Thousand USD | 20.51% |
| 2010 Q4 | 359.95 Thousand USD | 25.31% |
| 2010 Q3 | 287.25 Thousand USD | 75.57% |
| 2010 Q1 | 135.76 Thousand USD | -50.26% |
| 2009 Q2 | 483.72 Thousand USD | 90.76% |
| 2009 Q3 | 239.48 Thousand USD | -50.49% |
| 2009 Q4 | 272.95 Thousand USD | 13.97% |
| 2009 FY | - USD | -56.62% |
| 2009 Q1 | 253.57 Thousand USD | -61.77% |
| 2008 Q4 | 663.24 Thousand USD | -25.95% |
| 2008 Q2 | 725.05 Thousand USD | 21.46% |
| 2008 Q1 | 596.93 Thousand USD | -15.02% |
| 2008 FY | - USD | -25.78% |
| 2008 Q3 | 895.73 Thousand USD | 23.54% |
| 2007 FY | - USD | -4.93% |
| 2007 Q4 | 702.4 Thousand USD | -47.69% |
| 2007 Q3 | 1.34 Million USD | 28.89% |
| 2007 Q2 | 1.04 Million USD | 35.45% |
| 2007 Q1 | 769.11 Thousand USD | -38.78% |
| 2006 Q3 | 814.55 Thousand USD | -12.63% |
| 2006 Q4 | 1.25 Million USD | 54.22% |
| 2006 Q2 | 932.35 Thousand USD | 23.2% |
| 2006 FY | - USD | 20514.44% |
| 2006 Q1 | 756.76 Thousand USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 115.755% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | -2.84 Million USD | 146.085% |
| Cannabis Sativa, Inc. | -1.11 Million USD | 217.693% |
| CompuMed, Inc. | 690.19 Thousand USD | -90.053% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 99.384% |
| Cogstate Limited | 9.89 Million USD | 86.739% |
| CareView Communications, Inc. | -210.04 Thousand USD | 724.512% |
| Craneware plc | 54.26 Million USD | 97.583% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 110.671% |
| Certive Solutions Inc. | -704.66 Thousand USD | 286.15% |
| Drug Free Solution, Inc. | -1.39 Million USD | 194.036% |
| DATATRAK International, Inc. | 2.72 Million USD | 51.926% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 2099.287% |
| Healixa Inc. | -6.32 Million USD | 120.754% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 87.1% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 408.289% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | 454.184% |
| Cannabiz Mobile, Inc. | -750.00 USD | 174997.6% |
| Mednow Inc. | -28.12 Million USD | 104.664% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | 584.529% |
| MediXall Group, Inc. | -6.52 Million USD | 120.108% |
| Mitesco, Inc. | -11.96 Million USD | 110.965% |
| MobileSmith, Inc. | -13.83 Million USD | 109.48% |
| NantHealth, Inc. | -38.53 Million USD | 103.404% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 177.252% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | -12.08 Million USD | 110.853% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 110.842% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | -1655.295% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 10866.021% |
| Renalytix Plc | -28.52 Million USD | 104.599% |
| Revium Recovery Inc. | -678 Thousand USD | 293.471% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | -369.00 USD | 355582.927% |
| Vaso Corporation | 4.19 Million USD | 68.731% |
| Vynleads, Inc. | -235.72 Thousand USD | 656.465% |